Jane Street’s Soleno Therapeutics SLNO Stock Holding History

Jane Street’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-279,200	Closed	-$9.35M	–	12996
2026 Q1	$9.35M	Buy	279,200 +191,700	+219%	+$7.52M	﹤0.01%	2621
2025 Q4	$4.05M	Sell	87,500 -17,700	-17%	-$970K	﹤0.01%	3565
2025 Q3	$7.11M	Sell	105,200 -79,400	-43%	-$5.89M	﹤0.01%	2895
2025 Q2	$15.5M	Buy	184,600 +156,300	+552%	+$11.7M	﹤0.01%	1694
2025 Q1	$2.02M	Buy	28,300 +4,900	+21%	+$239K	﹤0.01%	4333
2024 Q4	$1.05M	Sell	23,400 -31,600	-57%	-$1.64M	﹤0.01%	5288
2024 Q3	$2.78M	Buy	+55,000	New	+$2.63M	﹤0.01%	3868

Jane Street's SLNO Position: Q2 2026 in Review

Jane Street sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 11,002 shares — an estimated $368K sold.

Jane Street first reported a position in SLNO in Q1 2015 and held it in 13 quarters. The position peaked at $6.56M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Jane Street reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 11,002 Soleno Therapeutics shares in Q2 2026, an estimated $368K.
Jane Street first reported a position in Soleno Therapeutics in Q1 2015 and held it in 13 quarters.
Jane Street's Soleno Therapeutics position peaked at $6.56M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.